Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 7, 2007
Grant Date -
Oct 27, 2005
app pub date -
Jun 28, 2005
filing date -
Jul 31, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention is directed to 1,2,3,4,10,10a,-hexahydropyrazino[1,2-a]indole derivatives as well as pharmaceutically acceptable salts, solvates and esters thereof, wherein R.sup.1 to R.sup.8 have the significance given in claim 1 be used in the form of pharmaceutical preparations for the treatment or prevention of disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully